0
Brainsway Ltd. Banner Image

Brainsway Ltd. has reached its limit for free report views

Work for Brainsway Ltd.? Upgrade Your Profile and unlock all your annual reports.

Brainsway Ltd.

  • Ticker BWAY
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Brainsway Ltd. Logo Image
  • 51-200 Employees
  • Based in Jerusalem, Israel
BrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neurostimulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology. The Company received marketing authorization from the U.S. Food and Drug Administration (FDA) for its products for a variety of patient populations, includingMore in 2013 for patients with major depressive disorder (MDD), in 2018 for patients with obsessive-compulsive disorder (OCD), and in 2020 for patients with smoking addiction. BrainsWay is currently conducting clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders.
Brainsway Ltd.

Most Recent Annual Report

Brainsway Ltd. MOST RECENT 2020 Annual Report

Report Locked. Brainsway Ltd. has reached its limit for free report views.

Older/Archived Annual Reports